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study question: Does intrauterine biosynthesis of estrogen play an important role in early pregnancy by altering the function of uterine
natural killer (uNK) cells?
summaryanswer: Estrogensdirectly regulate the functionof humanuNKcells by increasing uNKcellmigration and secretion of uNKcell-
derived chemokine (C-C motif) ligand 2 (CCL2) that critically facilitates uNK-mediated angiogenesis.
what is known already: uNK cells are a phenotypically distinct population of tissue-resident immune cells that regulate vascular
remodelling within the endometrium and decidua. Recently we discovered that decidualisation of human endometrial stromal cells results in
the generation of an estrogen-rich microenvironment in areas of decidualised endometrium. We hypothesize that intrauterine biosynthesis of
estrogens plays an important role in early pregnancy by altering the function of uNK cells.
study design, size, duration: This laboratory-based study used primary human uNK cells which were isolated from ﬁrst trimester
human decidua (n ¼ 32).
participants/materials, setting, methods: Primary uNKcellswere isolated fromﬁrst trimester human decidua usingmag-
netic cell sorting. The impact of estrogens on uNK cell function was assessed. Isolated uNK cells were treated with estrone (E1, 1028 M) or es-
tradiol (E2, 1028 M) alone or in combination with the anti-estrogen ICI 182 780 (ICI, 1026 M). uNK cell motility was assessed by transwell
migration assay and time-lapse microscopy. Expression of chemokine receptors was assessed by quantitative PCR (qPCR) and immunohisto-
chemistry, and angiogenic factors were assessed by qPCR and cytokine array. Concentrations of CCL2 in supernatants were measured by
enzyme-linked immunosorbent assay. Angiogenesis was assessed in a human endometrial endothelial cell network formation assay.
main results and the role of chance: Treatment with either E1 or E2 increased uNK cell migration (P ¼ 0.0092 and
P ¼ 0.0063, respectively) compared with control. Co-administration of the anti-estrogen ICI blocked the effects of E1 and E2 on cell migration.
ConcentrationsofC-X-Cchemokine receptor type4 (CXCR4)mRNA inuNKcellswere increasedbyE2 treatment. Thenetwork formation assay
revealed that conditioned media from uNK cells treated with E2 signiﬁcantly increased human endometrial endothelial cell (HEEC) angiogenesis
(P ¼ 0.0029 versus control). Analysis of media from uNK cells treated with E2 using an antibody array identiﬁed CCL2 as the most abundant
cytokine. Validation assays conﬁrmed concentrations of CCL2mRNA and protein were increased by E2 in uNK cells (P, 0.05 versus controls).
Comparedwith the control, recombinant humanCCL2was found to increaseHEECnetwork formation (P, 0.05) and neutralizationofCCL2 in
uNK conditioned media signiﬁcantly decreased E2-dependent uNK-mediated network formation (P ¼ 0.0006).
limitations, reasons for caution: Our results are based on in vitro responses of primary human cells and we cannot be certain
that similarmechanismsoccur in vivo in humans. Primary humanuNKcellswere isolated fromﬁrst trimester decidua at a rangeof gestations (8–12
weeks), which may be a source of variation. Primary human uNK cells from non-pregnant endometrium were not assessed and therefore the
responses of uNK cells to E2 treatment described in this study may be distinct to uNK cells from ﬁrst trimester decidua.
& The Author 2015. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse,
distribution, and reproduction in any medium, provided the original work is properly cited.
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wider implications of the findings: E2 is an essential regulator of reproductive competence. This study demonstrates a critical
role for E2 in regulating cellular cross-talk within the endometriumduring early pregnancy.Weprovide the ﬁrst evidence that E2 directly regulates
the function of human uNK cells by altering uNK cell migration and the secretion of uNK-derived angiogenic factors.We describe a novel mech-
anism of estrogen-dependent secretion of CCL2 which critically mediates uNK-dependent endometrial angiogenesis. Dysregulation of uNK cell
function has been implicated in the aetiology of early implantation disorders and disorders of pregnancy. These novel ﬁndings provide unique
insight into the regulation of uNK cell activity during the establishment of pregnancy in women and highlight key processes whichmay be targeted
in future therapeutic strategies.
study funding/competing interest(s): Studies undertaken in the authors’ laboratory were supported by MRC Programme
Grant G1100356/1 to P.T.K.S. The authors have no conﬂicts of interest to disclose.
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Introduction
The endometrium is a complex multicellular tissue that undergoes
dynamic remodelling in order to establish a microenvironment capable
of supporting a pregnancy. During the establishment of pregnancy
endometrial remodelling is characterized by three key processes; inﬂux
of uterine natural killer (uNK) cells, decidualisation (differentiation) of
stromal ﬁbroblasts and remodelling of the endometrial vasculature. Coor-
dinated regulation of these processes is critical for pregnancy success.
uNK cells are a phenotypically distinct population of tissue-resident
immune cells that are abundant in secretory phase endometrium and
ﬁrst trimester decidua (King et al., 1991). uNK cell numbers increase
fromDay 22 of the standardized 28 day cycle (Russell et al., 2013), coin-
cident with increasing levels of progesterone, increasing to be become
the predominant leukocyte population in ﬁrst trimester decidua. The
mechanisms that control accumulation and localization of uNK cells in
the uterus remain unresolved although there is evidence to suggest
that in situ proliferation, and recruitment and differentiation of NK cell
precursors and/or haematopoietic stem cells may contribute to the
rapid increase in cell numbers in the endometrium during the establish-
ment of pregnancy (King et al., 1991; Jones et al., 2004; Sentman et al.,
2004; Kitaya et al., 2005, 2007; Wu et al., 2005; Carlino et al., 2008;
Kane et al., 2009; Vacca et al., 2011). Although uNK cells do not
express progesterone receptors (Henderson et al., 2003), progesterone
indirectly promotes accumulation and differentiation of uNK cells in the
endometrium. For example, incubation with progesterone increases
synthesis and secretion of interleukin (IL)-15 from human endometrial
stromal cells in vitro (Okada et al., 2000) and treatment of women with
the selective progesterone receptor modulator Asoprisnil results in a
striking reduction in both IL15 mRNA and the number of CD56+
uNKcells detected in non-pregnant endometrium (Wilkens et al., 2013).
During the mid-secretory phase, decidualisation (differentiation) of
the stromal cells is ﬁrst detected adjacent to the spiral arteries in the
upper (functional) layer of the endometrium in response to the rising
levels of ovarian-derived progesterone. Decidualisation then spreads
‘wave-like’ throughout the tissue and if pregnancy ensues the cells
remain in situwithin the decidua of early pregnancy (reviewed in (Geller-
sen and Brosens, 2014)). Notably, decidualisation stimulates endomet-
rial stromal cells to secrete a number of growth factors and cytokines
that arekey regulatorsof immune cell function and vascular development
during endometrial remodelling. Recently we discovered that deciduali-
sation of human endometrial stromal cells also results in biosynthesis of
estrogens which we believe may be important in regulating early preg-
nancy tissue remodelling (Gibson et al., 2013).We described expression
of the estrogen biosynthetic enzyme aromatase in both ﬁrst trimester
human decidua and in decidualised human endometrial stromal cells.
In in vitro assays we detected secretion of signiﬁcant (nM) concentrations
of both estrone (E1) and estradiol (E2), from decidualised stromal
cells (Gibson et al., 2013). Given that human uNK cells are immunopo-
sitive for estrogen receptor (ER)b in tissue sections (Henderson et al.,
2003), these new data prompted us to explore whether the uNK cell
population could be responding to local concentrations of bio-available
estrogens in decidualised endometrium in early pregnancy.
Todate there is only limited evidence to suggest that uNKcellsmaybe
directly regulated by estrogens. DeLoia et al. reported that in women
who had received an artiﬁcial hormonal regimen to mimic the secretory
phase (progesterone and E2), increased numbers of uNK cells were
detected in endometrial biopsies when circulating estrogen concentra-
tions were increased (DeLoia et al., 2002) but whether the effects of
estrogens on uNK cells were direct or indirect was not explored. Most
of the data generated to explore the function of uNK cells in early preg-
nancy events has relied upon studies in mouse models including recent
reports that uNK cells play a role in regulating uterine vascular remodel-
ling in early pregnancy (Croy et al., 2012; Hofmann et al., 2014) and
reviewed in (Lima et al., 2014). However, as the uNK cells in mouse im-
plantation sites are reported to be devoid of ER mRNAs (Borzychowski
et al., 2003), we are only able to gain a greater understanding of uNK cell
regulationbyestrogens and their potential regulatory role in humanpreg-
nancy by performing studies using primary human uNK cells.
Isolated human uNK cells are reported to secrete angiogenic factors
such as vascular endothelial growth factor (VEGF) and placental
growth factor (PLGF) which promote angiogenesis in vitro and in vivo
(Hanna et al., 2006; Wallace et al., 2012). In women, histological
studies have revealed that uNK cells accumulate around spiral arterioles
and are abundant in perivascular sites in both late secretory phase endo-
metrium and in early pregnancy decidua (Bulmer et al., 1991). There is
convincing evidence that uNK cells regulate vascular remodelling
during trophoblast invasion and placentation (Lash et al., 2010, 2011;
Wallace et al., 2012). However, there is also accumulating evidence
that in early pregnancy spiral artery modiﬁcations in the decidua can
occur independently of cellular interactions with trophoblast cells
(Craven et al., 1998). For example, Histological studies have demon-
strated that changes in spiral arteries, such as loss of vascular smooth
muscle cells and endothelial cell breaks, are associated with maternal
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uNK cells but not fetal extravillous trophoblasts (Craven et al., 1998;
Smith et al., 2009). Studies utilizing co-cultures of placental villi and decid-
ual explants havedemonstrated that decidualmacrophages anduNKcells
initiate early stages of vascular remodelling (Hazan et al., 2010). In add-
ition, recent data support a role for uNK cells in promoting the early
stages of endometrial vascular remodelling through secretion of angio-
genic growth factors such as angiopoietin-2 (ANGPT2) (Robson et al.,
2012). Gestational differences in the secretion of angiogenic growth
factors from uNK cells puriﬁed and maintained for 48 h in culture have
been reported. For example, uNK cells recovered at 8–10 weeks gesta-
tion secreted more of the angiogenic growth factors VEGF-C and
ANGPT2 than uNK cells recovered at 12–14 weeks gestation (Lash
et al., 2006). Taken together these data suggest human uNK cells play a
key role in directly regulating vascular remodelling during early pregnancy.
Disorders of pregnancy are often associated with impaired vascular
remodelling and some studies have suggested that thismaybe associated
with alterations in uNK cell number and function although the data are
conﬂicting. For example, pre-eclampsia (PE) is a complex syndrome
with a multifactorial aetiology characterized by vascular pathology and
associated with defects in uterine spiral arteries. The associated role of
uNK cells in spiral artery modiﬁcations has led researchers to speculate
that uNK cells may be dysregulated in PE although this is still to be fully
elucidated. Although some studies report that decreased numbers of
uNK cells are associated with PE and fetal growth restriction (Williams
et al., 2009; Lockwood et al., 2013), Bachmayer et al. reported increased
uNK cells in term placental tissues from women with PE (Bachmayer
et al., 2006). uNK cell density is also reported to be proportional to
endometrial angiogenesis in women with recurrent reproductive
failure (Quenby et al., 2009). It has been proposed that an increase in
the number of uNK cells in the stroma underlying the luminal epithelium
of the endometriumofwomenduring the secretoryphase canbeused as
a diagnostic test to guide therapies for women suffering from infertility
(Tang et al., 2013). However, a recent meta-analysis that considered
22 studies found no signiﬁcant difference in the percentage of uNK
cells between fertile and infertilewomenand concluded thatNKcell ana-
lysis or immune cell therapy should only be considered in the context of
clinical research until further studies were conducted (Seshadri and
Sunkara, 2014).
In conclusion, it is generally accepted that coordinated cellular cross-
talk between decidualised stromal cells, uNK cells and the endometrial
vasculature is critical for appropriate regulation of endometrial remodel-
ling in early pregnancy. Despite an association between dysregulation of
uNK function and disorders of pregnancy, the fundamental mechanisms
underlying normal regulation of human uNK cell function remain unre-
solved. In the present studywe tested the hypothesis that estrogens pro-
duced by decidualised stromal cells (Gibson et al., 2013) can have a direct
impacton the functionof uNKcells.Weassessed the impactof estrogens
on human uNK cell motility and investigatedwhether E2 couldmodulate
changes in vascular function by directly inducing changes in production of
secreted factors from uNK cells.
Materials andMethods
Isolation of uNK cells
Decidual samples (n ¼ 32) were obtained from women requesting surgical
termination of pregnancy procedure with a mean gestation of 10 weeks
(range 8–12 weeks, Supplementary Table SI) dated according to the
woman’s reported last menstrual period. All women had an ultrasound
scan to conﬁrm viability of pregnancy and gestational age; none were over
12 weeks gestation. Local ethical committee approval was granted and
written informed patient consent was obtained prior to tissue collection
by a dedicated research nurse. (Ethical approval held by HODC; LREC/
05/51104/12 and LREC/10/51402/59). Primary human uNK cells were
isolated from human ﬁrst trimester decidua as described previously (Kane
et al., 2009) using magnetic separation and the MACSw system (Miltenyi
Biotech, Germany). uNK cells were isolated following CD3 depletion and
CD56 positive selection using the appropriate antibody-coated magnetic
microbeads. Isolated uNK cells were immuno-phenotyped using ﬂow cyto-
metry (Supplementary Fig. S1 and Supplementary Table SII).
uNK cell migration assay
Migration of uNK cells was assessed using a modiﬁed transwell migration
assay. Isolated uNK cells were treated with vehicle control (dimethyl sulfox-
ide, DMSO) or either 1028 ME1 or 1028 ME2, alone or in combinationwith
1026 M ICI 182 780 (ICI) for 1 h prior to assay (n ¼ 6 per group). Following
treatment, cells were pelleted and resuspended in culture media (Phenol
red-free RPMI 1640 plus 10% charcoal stripped fetal calf serum, Invitrogen)
prior to migration assay. Cell culture plates were coated with a 1.6 mg/ml
collagen gel (GIBCO/Invitrogen, A10644-01); serum-free, Phenol red-free
RPMI 1640 media was added to the well on top of the collagen matrix. Cell
culture plates were collagen coated prior to assay to provide an adherent
surface for attachment of migrated uNK cells. Cell culture inserts with a
5 mm membrane pore (Costar/Corning, 3421, NY, USA) were then
placed into the well into which the uNK suspension was added (2 × 105
cells per insert). Cells were treated in duplicate and left in the incubator to
migrate for 1 h. Migrated cells were counted by imaging 8 random ﬁelds
using Axiovert 200 Inverted Fluorescent Microscope (Zeiss) and the mean
number of migrated cells was calculated for each treatment. The fold
change compared with the vehicle control was plotted.
Immunoﬂuorescence
Expression of CD56, CXCR4 and C-X-C motif chemokine 12 (CXCL12) in
sections of human decidua (chosen because they have a very high abundance
of CD56+ cells) was determined by immunohistochemistry using standard
protocols and tyramide signal ampliﬁcation detection system (Perkin
Elmer). Primary antibodies; CXCL12 (mouse monoclonal antibody; R&D
systems MAB350), CXCR4 (mouse monoclonal antibody; R&D systems
MAB172) and CD56 (mouse monoclonal antibody; Zymed 18-0152) were
incubated overnight at 48C. Fluorescent images were examined using Zeiss
LSM 510 Meta-Confocal microscope.
uNK cell chemokinesis
The chemokinesis of uNK cells was assessed using Ibidim-SlideChemotaxis3D
chamber slides (Ibidi, 80 326, supplied by Thistle Scientiﬁc Ltd, Uddingston,
UK). Isolated uNK cells were suspended in a collagen matrix (as above) and
the response to E2 treatment was measured using time-lapse microscopy.
Chamber slides were set up containing serum-free phenol red-free RPMI
1640 media in both reservoirs and uNK cells were treated+E2. Cells were
imaged every 5 min for 4 h (n ¼ 30 per treatment) using an Axiovert 200
Inverted Fluorescent Microscope (Zeiss). Data were analysed using ImageJ
(manual cell tracking plug-in) and chemotaxis and migration tool software
(Ibidi).
Network formation assay
The formation of networks by telomerase immortalized human endometrial
endothelial cells (HEEC, gifted from Yale University, New Haven, CT, USA;
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(Schatz et al., 2000)) was assessed as described previously (Greaves et al.,
2013). HEECs were derived from primary human endometrial endothelial
cells as described in Schatz et al. (2000) and immortalized as described in
Krikun et al. (2005). HEEC express classic endothelial cell markers, such as
vonWillebrand factor (VwF) and platelet/endothelial cell adhesionmolecule
1 (PECAM1, CD31), and transcriptional analysis by microarray conﬁrmed
93% identity with parent primary endothelial cells (Krikun et al., 2005);
prior to use in the assays described in this paper expression of CD31 and
VwF was reconﬁrmed as described previously (Greaves et al., 2013).
Isolated uNK cells were cultured at a density of 1 × 106 cells per/ml and
treated with 1028 M E2, 1026 M ICI or a combination of E2 and ICI for 24 h
(n ¼ 10 per group). Following treatment, cells were pelleted and the super-
natant, uNK cell conditionedmedia (CM), were stored at2808Cuntil assay.
uNKCMwas thawed immediately prior to assay and warmed to 378C. uNK
CM or phenol red-free RPMI 1640 media containing recombinant human
chemokine (C-C motif) ligand 2 (CCL2) (RnD; Cat #279-MC-010) was
added to the bottom chambers.Where appropriate, the pure anti-estrogen
ICI was added into the upper chamber for 1 h before the addition of
uNK-CM. Neutralization of CCL2 was achieved by incubating treatment
media with a monoclonal antibody to CCL2 (mAb-CCL2; Monoclonal
Mouse IgG1 Clone # 24822, RnD; Cat # MAB279) for 1 h prior to assay.
HEEC were incubated for 16 h at 378C to allow formation of networks.
Network formationwas visualized using anAxiovert 200 Inverted Fluorescent
Microscope and analysed as described previously (Greaves et al., 2013).
Network formation was quantiﬁed as fold change relative to comparator.
Angiogenesis RT2 proﬁler PCR array
RT2 proﬁler PCR arrays (SABiosciences, Frederick, MD, USA) were utilized
to analyse a targeted panel of 84 genes related to angiogenesis. uNK cells
were isolated from three patients and treated +E2 for 2 h. Total RNA
was extracted from uNK cells using a Qiagen RNAeasy kit (Qiagen, UK)
according to manufacturer’s instructions and retrotranscribed using a RT2
single strand cDNA synthesis kit (SAB Biosciences, Frederick, MD, USA).
PCR array data analysis was performed using the SABiosciences web
portal according to the DDCt method (http://www.SABiosciences.com/
pcrarrayanalysis.php).
Expression of mRNAs encoding C-X-C chemokine receptor type 4
(CXCR4), Interleukin-15 receptor alpha (IL15RA), interferon gamma (IFNG)
and CCL2 was assessed by quantitative PCR (qPCR) according to standard
protocols. Samples were quantiﬁed using the comparative DDCt method
with ribosomal 18S as internal control reference gene. The primers/
probes are given in Supplementary Table SIII. PCR primers were designed
using the Roche Universal Probe Library Assay Design Center. Primer
efﬁciency was between 90 and 110% and amplicon sizes were conﬁrmed
(Supplementary Fig. S2).
Cytokine array
The relative abundance of 60 cytokines in uNK CMwas assessed using Ray-
biotech Human Cytokine Array (Cat# AAH Cyt-6) and visualized using the
Odysseyw system (LiCor). Relative cytokine expression levels were deter-
mined by assessing signal intensities using Odyssey application software.
Milliplex assay
The concentration of CCL2 in uNK CM (n ¼ 5 per group) was quantiﬁed
using a customized singleplex bead enzyme-linked immunosorbent assay
(HCYTOMAG-60 K, Millipore, Schwalbach, Germany) according to manu-
facturer’s instructions. Standards and samples were measured in duplicate
using a Bio-Plex 200 HTF machine and analysed using BioPlex Manager Soft-
ware (Version 5, BioRad).
Statistical analysis
Statistical analysis was performed using Graphpad prism (GraphPad Soft-
ware, Inc., La Jolla CA, USA). Student’s t-test was used to determine signiﬁ-
cance between treatments in data that were normally distributed.
Non-parametric testing was utilized where sample sizes were insufﬁcient
to conﬁrm normality of data distribution. Mann–Whitney test was used to
assess differences between treatments. Where data were analysed as fold
change, signiﬁcance was tested using one-sample t-test and a theoretical
mean of 1. Criterion for signiﬁcance was P, 0.05. All data are presented
as mean+ SEM.
Results
Estrogens promote uNK cell motility
In agreement with results of tissue immunohistochemistry (Henderson
et al., 2003) uNKcells freshly isolated fromﬁrst trimester decidua (deter-
mined to be.93%pure; Supplementary Fig. S1) were shown to express
ERbmRNAandprotein butwere immunonegative for ERa (Supplemen-
tary Fig. S3). To determinewhether estrogens could have a direct impact
on uNK cell motility, cells were treated with either E1 (1028 M) or E2
(1028 M) in thepresenceorabsenceof theanti-estrogen ICI (fulvestrant,
1026 M). Treatmentwith E1or E2 signiﬁcantly increased uNKcellmigra-
tion (Fig. 1A and B; n ¼ 6 per treatment, P ¼ 0.0092 and P ¼ 0.0063,
respectively) and co-administration of ICI blocked the effect of either
E1 (P ¼ 0.0022) or E2 (P ¼ 0.026).
To complement and extend these studies, uNK cell motility was
recorded using live cell imaging and time-lapse microscopy (Supplemen-
tary Videos S1 and S2). When cell movement was analysed using the
chemotaxis and migration tool software (Ibidi) an increase in cellular
activity was readily apparent following exposure to E2. Chemokinesis
(non-directed cell movement) was measured: E2 treatment (1028 M)
was found to signiﬁcantly increase both the velocity and the accumulated
distance travelled by uNK cells (Fig. 1C and D, P, 0.01, n ¼ 30 per
treatment) compared with control (DMSO).
During decidualisation endometrial stromal cells secrete estrogens
(Gibson et al., 2013) as well as uNK chemoattractants such as
CXCL12 and IL-15 (Kitaya et al., 2005; Wu et al., 2005). To investigate
whether E2 could increase responsiveness of uNK cells to chemoattrac-
tants, the expression of the CXCL12 receptor (CXCR4) and the IL-15
receptor alpha (IL15Ra) was assessed in uNK cells by qPCR. E2 treat-
ment up-regulated concentrations of mRNAs encoding CXCR4
(Fig. 1E, P ¼ 0.0585, n ¼ 5) while concentrations of IL15RA were un-
changed by E2 (Fig. 1F). Consistent with previous ﬂow cytometry
studies (Wu et al., 2005), ﬂuorescent immunohistochemistry analysis
of humandecidua revealed thatCD56+ uNKcellswereCXCR4positive
(Fig. 1G). Furthermore, uNK cells (asterisks) appeared to accumulate
near to CXCL12-positive decidualised stromal cells (white arrows,
Fig. 1H). Interestingly, CXCR4 was immunolocalised to the nuclei of
CD56+ cells, consistent with nuclear re-localization as a result of
CXCL12 stimulation (Wang et al., 2009).
Estradiol promotes uNK-mediated
angiogenesis
uNK cells are reported to secrete angiogenic factors and to promote
angiogenesis in vitro and in vivo (Hanna et al., 2006). Recent reports
suggest uterine artery remodelling and angiogenesis both occur in early
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pregnancy (Lima et al., 2014). We investigated the effect of E2 on
uNK-mediated angiogenesis using an established in vitro assay (Greaves
et al., 2013) of endothelial network formation which is considered a
morphometric assay that models the reorganization stage of angiogen-
esis. HEEC network formation was assessed in response to CM from
uNK cells treated with E2 (1028 M), the anti-estrogen ICI (1026 M) or
Figure 1 Estrogens promote uNK cell migration and chemokinesis. Uterine natural killer (uNK) cells were treated in duplicate with estrone (E1) or es-
tradiol (E2) alone or in combinationwith the anti-estrogen ICI 182, 780 (ICI). Relative fold change responseswere comparedwith vehicle control (dimethyl
sulfoxide,DMSO). (A) E1 signiﬁcantly increased uNK cellmigration by1.8-fold (n ¼ 6,One-sample t-test, P ¼ 0.0092), co-administration of ICI blocked
E1-mediated increasedmigration (Mann–Whitney test, P ¼ 0.0022). (B) E2 signiﬁcantly increased uNK cell migration 2.6-fold (n ¼ 6, One-sample t-test,
P ¼ 0.0063), co-administration of ICI blocked E2-mediated increased migration (Mann–Whitney test, P ¼ 0.0260). uNK cell motility in cells treated with
vehicle control (DMSO, n ¼ 30 cells) or E2 (n ¼ 30 cells) was assessed using time-lapse videomicroscopy (Supplementary Videos S1 and S2). (C) E2 treat-
ment signiﬁcantly increased uNK cell velocity (mm/min) compared with vehicle control (Student’s t-test, P ¼ 0.0016). (D) E2 treatment signiﬁcantly
increased the accumulated uNK cell distance (mm) compared with vehicle control (Student’s t-test, P ¼ 0.0016). The expression of chemokine receptors
in uNK cells in response to E2 was assessed by quantitative PCR (qPCR); fold change compared with vehicle control was determined. (E) E2 tended to
increase concentrations of mRNAs encoding C-X-C chemokine receptor type 4 (CXCR4) (n ¼ 5, One-sample t-test, P ¼ 0.0585). (F) IL15RA mRNA
was unchanged. The expression of the uNK chemoattractant C-X-C motif chemokine 12 (CXCL12) and its receptor CXCR4 were assessed in ﬁrst tri-
mester human decidua by immunohistochemistry. (G) Positive staining for CXCR4 (green) was detected in CD56-positive uNK cells (red staining).
(H) CXCL12 did not co-localize with CD56-positive uNK cells (asterisks); however, positive staining was detected in decidualised stromal cells
(arrows) and epithelial cells (green staining) in decidua. Nuclear counterstain DAPI (blue staining). Scale bar 50 mm. *P, 0.05, **P, 0.01.
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Figure 2 Estradiol promotes uNK-mediated network formation in endometrial endothelial cells via uNK estrogen receptor. Human endometrial endo-
thelial cell (HEEC) network formationwas assessed in response to uNKconditionedmedia (CM).Network formationwasquantiﬁed as fold change relative
to vehicle control. (A) CM from uNK cells treated with E2 signiﬁcantly increased network formation in HEECs (n ¼ 10, One-sample t-test, P ¼ 0.0029).
(B) Blocking of HEEC estrogen receptor (ER)b with ICI did not affect uNK-mediated increased network formation (n/s: not signiﬁcant, n ¼ 3, Mann–
Whitney test). (C) CM from uNK cells treated with ICI or uNK cells treated with E2 in combination with ICI (E2+ICI) had no signiﬁcant impact on
network formation. CM from uNK cells treated with E2 signiﬁcantly increased network formation relative to all treatments including endothelial basal
growth media (EBM, P ¼ 0.002). CM from uNK cells co-treated with E2 and ICI signiﬁcantly decreased network formation compared with CM from
uNK cells treated with E2 alone (n ¼ 7, Mann–Whitney test, P ¼ 0.0136). *P, 0.05, **P, 0.01. Images were captured at ×5 magniﬁcation using the
Axiovert 200 Inverted Fluorescent Microscope.
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E2 in combination with ICI. CM from uNK cells treated with E2 signiﬁ-
cantly increased network formation compared with control (Fig. 2A,
P ¼ 0.0029, n ¼ 10). We have previously reported that HEEC can
respond to estrogens via activation of ERb (Greaves et al., 2013); there-
foreweblocked any indirect stimulation ofHEECby E2 present inCMby
pre-treating HEEC with the anti-estrogen ICI (1026 M). Pretreatment
with ICI did not affect HEEC network formation in response to uNK
CM (Fig. 2B, n ¼ 3). Finally, we conﬁrmed that the secretion of
pro-angiogenic factors from uNK cells in response to E2 was receptor
mediated, as CM from uNK cells treated with E2+ICI did not increase
HEEC network formation (Fig. 2C, P ¼ 0.0136, n ¼ 7).
Targeted gene analysis reveals regulation
of cytokines in uNK cells
To investigatewhether treatmentwith E2had an impact onexpressionof
genes known to play a role in angiogenesis, mRNAs expressed by uNK
cells were assessed using a targeted PCR array (SAB biosciences). The
identityofmRNAswith alteredexpression is summarized inTable I.Mes-
senger RNAs encoded by VEGFC and PLGF, previously reported to be
uNK-derived angiogenic factors (Hanna et al., 2006), were not detected
and VEGFA expressionwas not affected by E2 treatment (Table I, n ¼ 3).
CCL2 and IFNG were selected for follow-up validation as these were
the top two targets that exhibited greatest increased regulation in re-
sponse to E2. Targeted analyses of IFNG and CCL2 were validated in a
separate larger sample set of E2-treated uNK cells using qPCR and
were increased in response to 1028 M E2 (Fig. 3A; P ¼ 0.0394, n ¼ 10
and Fig. 3B; P ¼ 0.0565, n ¼ 9, respectively).
To assess if changes in gene transcriptionwere reﬂected in alterations in
secretion of pro-angiogenic factors the relative abundance of cytokines/
growth factors in uNK-E2 CM was assessed using a Human Cytokine
Array. Levels of IFNG were low but CCL2 was abundant in uNK-E2 CM
comparedwith other cytokines/growth factors (Fig. 3C). The concentra-
tion of CCL2 was quantiﬁed by Milliplex bead assay. Concentrations of
CCL2 (mean concentration 0.1 ng/ml) were signiﬁcantly increased in
CM from E2-treated uNK cells (Fig 3D, P ¼ 0.0408, n ¼ 5).
E2-dependent secretion of CCL2 promotes
uNK-mediated angiogenesis
To investigatewhetherCCL2could directly promote endometrial angio-
genesis, the impact of recombinant human CCL2 (rCCL2) on network
formation by HEEC was assessed. A biphasic dose-dependent increase
in HEEC network formation was detected in response to rCCL2 that
was signiﬁcant at 0.1 ng/ml (Fig. 4A, P ¼ 0.0348, n ¼ 4) and 0.5 ng/ml
(Fig 4A, P ¼ 0.0470, n ¼ 4) but inhibited at concentrations ≥5 ng/ml.
Interestingly, the concentration of CCL2 detected in uNK CM (0.1 ng/
ml) was comparable to the dose of rCCL2 which produced a signiﬁcant
response. The capacity for increasing concentrations of a monoclonal
antibody to CCL2 (mAb-CCL2) to neutralize rCCL2-mediated
network formation was tested against 0.5 ng/ml rCCL2. Incubation
with mAb-CCL2 for 1 h prior to assay was sufﬁcient to signiﬁcantly
inhibit network formation at mAb-CCL2 concentrations of 0.1 mg/ml
(P ¼ 0.0174, n ¼ 4) and greater (Fig. 4B, 0.5 mg/ml; P ¼ 0.0026,
1 and 5 mg/ml; P ¼ 0.0005, n ¼ 4).
To conﬁrmwhetherCCL2was the key E2-dependent factor secreted
by uNK cells that could induce changes in vascular endothelial cells, CM
from uNK cells treated with E2 was incubated with 0.5 mg/ml
mAb-CCL2before itwasused to assessHEECnetwork formation.Neu-
tralization of CCL2 resulted in a signiﬁcant decrease in E2-dependent
uNK-mediated network formation (Fig. 4C, P ¼ 0.0006, n ¼ 8).
Discussion
This study demonstrates that estrogens directly regulate the bioactivity
of human uNK cells. Although there has been evidence to suggest
uNK cells can be regulated indirectly by sex steroid hormones such as
progesterone, this study provides the ﬁrst evidence that estrogens are
direct mediators of uNK cell function. Collectively, our novel ﬁndings
indicate that estrogens increase uNK cell migration and responsiveness
to chemoattractants. We report evidence that secretion of CCL2
from uNK cells is ER-dependent and that CCL2 critically facilitates
uNK-mediated endometrial angiogenesis. These results support
our hypothesis that estrogens synthesized within endometrial tissue
promote regulation of uNK cells, leading to ER-dependent secretion of
pro-angiogenic factors that promote vascular remodelling.
Understanding the dynamic changes that take place in the endometrium
during the establishment of pregnancy is challenging. Our results provide
new insights into the regulation of human endometrial remodelling and
highlight the importance of cellular cross-talk between decidualised
stromal cells, uNK cells and the endometrial vasculature. Decidualisation
ofendometrial stromal cells isaprogressiveprocesscharacterizedbyatime-
dependent change in the ratios of secreted estrogens (E1 and E2).Wehave
previously demonstrated that primary endometrial stromal cells induced to
decidualise in vitro initially secrete a high E1:E2 ratio, followed by a progres-
sive increase in E2 such that the concentration of E1 is equivalent to that
of E2 when cells are fully transformed (Gibson et al., 2013). Interestingly,
........................................................................................
Table I Differential expression of angiogenesis genes in
uterine natural killer (uNK) cells treated with estradiol
(E2).
Gene of interest Fold change P-value
VEGFA 1.007 0.756185
MMP9 1.4272 0.150482
PECAM1 1.7144 0.29493
MMP2 1.7916 0.066499
CXCL10 1.9562 0.446108
TIMP1 2.6924 0.105164
CCL2 2.8044 0.128538
IFNG 4.4089 0.108815
Top targets that were subsequently validated are listed in bold.
uNK cells were treated with control (dimethyl sulfoxide) or E2 for 2 h (n ¼ 3) and the
differential expression of angiogenesis genes was determined. PCR array data analysis
was performed using the SABiosciences web portal according to the DDCt method
(http://www.SABiosciences.com/pcrarrayanalysis.php) and gene expression
expressed as fold change relative to vehicle control. The P-values are calculated based
on a Student’s t-test of the values for each gene in the control group and treatment
groups. Angiogenesis genes that were differentially up-regulated in response to E2 are
shown. Expression of vascular endothelial growth factor A (VEGFA) is also shown for
comparison.
MMP9, matrix metallopeptidase 9; PECAM1, platelet/endothelial cell adhesion
molecule 1; MMP2, matrix metallopeptidase 2; CXCL10, chemokine (C-X-C motif)
ligand 10; TIMP1, TIMP metallopeptidase inhibitor 1; CCL2, chemokine (C-C motif)
ligand 2; IFNG, interferon gamma.
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in the present study, similarmolar concentrations of E1 and E2were able to
signiﬁcantly increase the numbers of migrating uNK cells, a ﬁnding that was
unexpected as E1 is considered to be a much ‘weaker’ estrogen than E2.
However these assumptions about the activity of E1 are based on results
reporting a lower binding afﬁnity for ER and 10-fold lower activation of es-
trogen response element-driven reporter constructs in cell lines than E2
(Kuiper et al., 1998; Legler et al., 2002). Notably, the E1- and E2-driven
increases in uNK cell migration were both abrogated by treatment with
the pure ER antagonist ICI (Wakeling et al., 1991). The novel ﬁnding that
E1 increases uNK migration may indicate a role for E1 in maintaining
tissue-resident uNK cells during the secretory phase, while increasing con-
centrations of E2 that occurwith decidualisation and establishment of preg-
nancy (Gibson et al., 2013) may enhance accumulation of uNK cells in
decidua and inﬂuence recruitment of uNK cells within the endometrium
in early pregnancy (Fig. 5; 1 and 2).
Decidualised endometrial stromal cells secrete uNK chemoattrac-
tants such as CXCL12 (Kitaya et al., 2005;Wu et al., 2005). The expres-
sion and secretion ofCXCL12 in endometrial stromal cells is reported to
be promoted by E2 but suppressed by progesterone (Glace et al., 2009).
Thus, areasof endometriumwith increasedbioavailability of E2mayhave
increased concentrations of CXCL12. In the present study, immuno-
ﬂuorescence highlighted the close association of CXCL12-positive
stromal cells and CXCR4-positive uNK cells within human decidua
and revealed that CXCR4 was immunolocalised to the nuclei of uNK
cells (indicative of receptor activation) (Wang et al., 2009). In addition,
E2 treatment increased concentrations of CXCR4 mRNA in isolated
uNK cells, which suggests that E2 could enhance responsiveness of
uNK cells to CXCL12. This may be of increasing importance in early
pregnancy as primary human trophoblast cells also secrete CXCL12
(Wu et al., 2005). E2 may therefore inﬂuence the recruitment of uNK
cells to invading trophoblast cells by altering CXCR4 expression and
this may impact on uNK cell activity during the establishment of the
materno–fetal interface. Collectively, our new ﬁndings provide the
ﬁrst evidence that the bioavailability of estrogens within the decidua
could increase uNK cell migration, motility and responsiveness to
chemoattractants.
uNK cells promote vascular remodelling during the establishment of
pregnancy.The current study investigated the impactof E2onexpression
of angiogenic factors in uNK cells. We found that CCL2 mRNA and
protein concentrations were increased by E2 treatment in uNK cells in
an ER-dependent manner (Fig. 5; 3 and 4). Transcriptional analysis of
uNKcells did not reveal E2-dependent changes in angiogenic factors pre-
viously associated with uNK cells such as VEGFA and IFNG. In addition,
VEGFC and PLGF were not detected by PCR array. This may indicate
limited sensitivity of the PCR array or that the secreted proteins are
more easily detectable than mRNA transcripts for these genes which
Figure 3 E2-dependent regulation of angiogenic factors in uNK cells. The top two targets identiﬁed by PCR array; chemokine (C-C motif) ligand 2
(CCL2) and interferon gamma (IFNg), were selected for follow-up validation by qPCR. Fold change compared with vehicle control was determined.
(A) E2 signiﬁcantly increased expression of CCL2mRNA (n ¼ 10, One-sample t-test, P ¼ 0.0394) compared with control (DMSO). (B) Concentrations
ofmRNAsencoding IFNG tended tobe increasedbyE2 treatment (P ¼ 0.0565, n ¼ 9). (C)Cytokines/growth factors inCMfromuNKcells treatedwith E2
wereassessed by cytokine array; levels of IFNgwere low/undetectable,CCL2was abundant. (D)Concentrations ofCCL2were assessedbyMilliplexbead
assay. Concentrations of CCL2 were signiﬁcantly increased in CM from uNK cells treated with E2 (n ¼ 5, One-sample t-test, P ¼ 0.0408 versus control).
*P, 0.05, **P, 0.01.
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may be subject to rapid mRNA turnover. CM from uNK cells contained
a number of angiogenic factors all of which may contribute to regulation
of the vasculature. We speculate that E2 may modulate production
of only a limited subset of angiogenic factors, such as CCL2, which
may act in addition to, or in synergism with, other uNK cell-derived
factors, such as VEGFA, that are not inﬂuenced by the bioavailability
of E2. However, blocking E2 action in uNK cells or neutralizing CCL2
abrogated the increases in network formation in our model system
consistent with CCL2 being a key target for E2-dependent regulation
in uNK cells.
Figure 4 E2-dependent secretion of CCL2 regulates uNK-mediated angiogenesis. HEEC network formation was assessed in response to recombinant
human CCL2 (rCCL2). (A) Network formation was signiﬁcantly increased in response to 0.1 ng/ml rCCL2 (n ¼ 4, One-sample t-test, P ¼ 0.0348) and
maximal in response to0.5 ng/ml (n ¼ 4,One-sample t-test,P ¼ 0.047). (B)HEECwere incubatedwith0.5 ng/ml rCCL2and increasing concentrationsof
a monoclonal antibody to CCL2 (mAb-CCL2). HEEC network formation was assessed relative to 0 mg/ml mAb-CCL2. Neutralization of rCCL2 with
mAb-CCL2 signiﬁcantly inhibited HEEC network formation at concentrations of 0.1 mg/ml (P ¼ 0.0174) and greater (n ¼ 4, One-sample t-test,
0.5 mg/ml; P ¼ 0.0026, 1 and 5 mg/ml; P ¼ 0.0005). (C) uNK-E2 CM was incubated with 0.5 mg/ml mAb-CCL2 and HEEC network formation was
assessed relative to control uNK CM (DMSO). Neutralization of CCL2 signiﬁcantly reduced HEEC network formation (n ¼ 8, One-sample t-test,
P ¼ 0.0069) and reversed uNK-E2-mediated increased network formation (n ¼ 8, Mann–Whitney, P ¼ 0.0006). *P, 0.05, **P, 0.01, ***P, 0.001.
Images were captured at ×5 magniﬁcation using the Axiovert 200 Inverted Fluorescent Microscope.
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We have previously demonstrated that CCL2 is immunolocalised to
perivascular cells in ﬁrst trimester human decidua (Jones et al., 1997);
however, in vitro studies suggest that both progestins and E2 inhibit
CCL2 expression in human endometrial stromal cells (Arici et al.,
1999). This may indicate that E2-stimulated uNK cells may be the princi-
pal source of CCL2 in the endometrial microenvironment in early preg-
nancy. uNK cells are reported to express chemokine (C-C motif)
receptor 2 (CCR2), the CCL2 receptor, and CCL2 is reported to de-
crease apoptosis and increase proliferation of decidual leukocytes (the
majority of which are uNK cells) (He et al., 2012). Thus, CCL2 secreted
from uNK cells in response to E2 may have an autocrine impact on uNK
cell function and promote persistence/survival in the decidua.
Previous studies investigating the effect of uNK cells on angiogenesis
have used human umbilical vein endothelial cells (HUVEC) in network
formation assays; however, we and others have reported that endothe-
lial cells from different vascular beds have distinct characteristics and
responses (Schatz et al., 2000; Greaves et al., 2013). To the best of
our knowledge the results in the current study represent the ﬁrst
in vitro evidence of the impact of uNK cells on endothelial cells from
human endometrium (HEEC). Interestingly, while E2 is an established
regulator of network formation in HUVEC (Morales et al., 1995),
recent studies using an in vitro model suggest that direct stimulation of
human endometrial endothelial cells with E2 has no signiﬁcant effect
on HEEC network formation (Greaves et al., 2013). We speculate that
indirect stimulation of the vasculature by E2, relayed via uNK cells,
may prevent excessive activation of angiogenesis and lead to controlled,
site-speciﬁc vascular remodelling in areas of the tissue that havehigh local
bioavailability of E2 and associated accumulation of uNK cells.
Tissue-resident uNK cells are a highly dynamic cell population that
varies throughout pregnancy. Gestation-dependent changes in killer-cell
immunoglobulin-like (KIR) receptor repertoire have been reported in
uNKcells isolated fromﬁrst trimester decidua from6 to 12weeks of ges-
tation (Sharkey et al., 2008; Marlin et al., 2012). This may be particularly
important in early pregnancy as changes in NK receptor expression are
reported to alter secretion of growth factors and cytokines from uNK
cells which in turn may impact on the regulation of endometrial remod-
elling (Hanna et al., 2006; Sharkeyet al., 2008).Consistentwith this, func-
tional activity of uNK cells is reported to vary with gestational age.
Trophoblast invasion is stimulated by factors secreted from uNK cells
from 12 to 14 weeks gestation but not 8–10 weeks gestation and secre-
tion of angiogenic growth factors from uNK cells decreases with gesta-
tional age (Lash et al., 2006, 2010). In the present study, uNK cells
were isolated from human decidua between 8 and 12 weeks gestation
(Supplementary Table SI) which may be a source of variation within
our results. Interestingly, despite the variation in gestation the observed
responses to E2 were consistent for all end-points which may indicate
that E2 regulates uNK cell function independent of gestational age;
however, further studieswouldbe required todetermine this. Transcrip-
tional proﬁling suggests that human uNK cells from non-pregnant endo-
metrium are distinct from uNK cells isolated from decidua (Kopcow
et al., 2010). In our study we did not assess the impact on uNK cells
isolated from non-pregnant endometrium due to the limitations of
obtaining a sufﬁcient yield of uNKcells fromendometrial pipelle biopsies.
However, as decidualisation of stromal cells begins in the mid-secretory
phase, further studies arewarranted to investigatewhether the function-
al effects of E2 on decidual uNK cells are replicated in uNK cells from
non-pregnant endometrium.
In summary, the present study providesmechanistic insight and critical
new evidence modelling the physiological regulation of human uNK cell
function and cell–cell interactions within the uterinemicroenvironment.
Given our newdata, it is conceivable that defects in estrogen-dependent
processes may inﬂuence uNK cell function and hence targeting estrogen
action could provide a new therapeutic strategy.
Supplementary data
Supplementary data are available at http://humrep.oxfordjournals.org.
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